Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bottrop
Clinical trial register · Germany

Clinical Trials in Bottrop, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company4 Gilead Sciences3 Institut fuer Frauengesundheit2 AstraZeneca2 Alliance Foundation Trials, LLC.2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Bottrop

30 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Eli Lilly and Company
Phase 2
600
Bergisch Gladbach, Berlin, Bielefeld, Bochum, Bonn, Bottrop, Bremen, Cottbus
2026-05-13
Recruiting
Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
NCT07510984Heterotopic Gastric Mucosa of the Proximal Esophagus, Gastric Inlet Patches, Dysphagia, Dyspepsia
Knappschaft Kliniken GmbH
Observational
721
Bottrop
2026-03-24
Recruiting
Eli Lilly and Company
Phase 3
800
Berlin, Bottrop, Cologne, Dessau, Donauwörth, Dresden, Düsseldorf, Erlangen
2025-12-22
Recruiting
University Hospital Tuebingen
Phase 3
150
Saarlouis, Berlin, Bottrop, Dresden, Marburg, Tübingen, Wolfach
2025-10-27
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Aschaffenburg, Bottrop, Dresden, Eggenfelden, Erlangen, Freiburg im Breisgau, Krefeld, Mannheim
2025-08-26
Recruiting
AstraZeneca
Observational
150
Amberg, Bad Nauheim, Bautzen, Berlin, Bielefeld, Bonn, Borna, Bottrop
2025-05-20
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Karlsbad, Bad Neustadt an der Saale, Bamberg, Bochum, Bottrop, Erfurt, Essen, Frankfurt
2025-03-14
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Essen, Bottrop, Dresden, Leipzig, Mönchengladbach, München, Münster, Wolfsburg
2024-07-31
Active, closed
MedSIR
Phase 2
165
Bottrop, Essen, Hamburg, München
2024-07-22
Active, closed
AbbVie
Observational
427
Wolfach, Munich, Potsdam, Osnabrück, Halle, Beelitz-Heilstätten, Bottrop
2024-01-24
Active, closed
DualityBio Inc.
Phase 3
541
Erlangen, Wiesbaden, Bottrop, Cologne, Witten, Dresden, Berlin
2024-01-18
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Aachen, Augsburg, Bergisch Gladbach, Bottrop, Bremen, Cologne, Dresden, Hanover
2023-12-15
Recruiting
Hoffmann-La Roche
Phase 3
230
Amberg, Berlin, Bottrop, Düsseldorf, Erfurt, Erlangen, Freiburg im Breisgau, München
2023-09-08
Active, closed
Gilead Sciences
Phase 3
654
Baden-Württemberg, Bayern, Berlin, Bottrop, Erlangen, Gera, Hamburg, Hanover
2023-05-08
Recruiting
Magseed Pro(R)/ Sentimag(R) Gen3
NCT05142787Breast Cancer
Endomagnetics Ltd.
Not applicable
224
Bottrop, Frankfurt, Munich
2023-03-02
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Augsburg, Bayreuth, Berlin, Bottrop, Braunschweig, Bremen, Chemnitz, Dessau
2022-12-16
Recruiting
Gilead Sciences
Phase 3
1,514
Augsburg, Berlin, Bielefeld, Bottrop, Braunschweig, Bremen, Cologne, Dortmund
2022-12-12
Recruiting
Institut fuer Frauengesundheit
Phase 4
1,000
Erlangen, Mainz, Bottrop, Amberg, Aschaffenburg, Augsburg, Bamberg, Berlin
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
Augsburg, Berlin, Bottrop, Cologne, Dessau, Donauwörth, Dortmund, Düsseldorf
2022-10-04
Active, closed
Genentech, Inc.
Phase 3
373
Bottrop, Erlangen, Essen, Heidelberg, Mainz
2022-08-03
Active, closed
Institut fuer Frauengesundheit
Phase 2
11
Tübingen, Ulm, Erlangen, Bottrop, Düsseldorf, Berlin
2022-07-30
Active, closed
Gilead Sciences
Phase 3
443
Berlin, Bonn, Bottrop, Cologne, Erlangen, Essen, Freiburg im Breisgau, Hamburg
2022-07-25
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Augsburg, Bad Nauheim, Berlin, Bonn, Bottrop, Dessau, Düsseldorf, Erfurt
2021-05-04
Active, closed
Toralf Reimer, MD PhD
Not applicable
350
Augsburg, Baden-Baden, Berlin, Bochum, Borna, Bottrop, Böblingen, Cottbus
2021-01-13
Recruiting
Occlutech International AB
Observational
150
Bottrop, Coburg, Cologne, Erfurt, Hamburg, Heide, Jena, Osnabrück
2020-10-28
Active, closed
Eli Lilly and Company
Phase 3
996
Pforzheim, Würzburg, Frankfurt am Main, Lauterbach, Hanover, Bottrop, Wipperfürth, Leipzig
2020-06-22
Active, closed
Fondazione Michelangelo
Phase 3
650
Berlin, Bottrop, Coburg, Dortmund, Dresden, Frankfurt, Gera, Greifswald
2018-09-07
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Bottrop, Cologne, Essen, Frankfurt, Hanover, Kiel, Münster, Schweinfurt
2017-06-21
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Aachen, Berlin, Bottrop, Braunschweig, Ebersberg, Eggenfelden, Erlangen, Frankfurt
2015-08
Active, closed
AstraZeneca
Phase 3
1,837
Aachen, Augsburg, Baden-Baden, Berlin, Bonn, Bottrop, Brandenburg, Bremen
2014-04-22
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/bottrop

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Bottrop.

How many clinical trials are recruiting in Bottrop?

14 of the 30 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bottrop), 30 studies
PhaseStudiesRecruitingShare
Phase 319763.3%
Observational4313.3%
Phase 23110%
Not applicable216.7%
Phase 4226.7%

Most active sponsors

Lead sponsors with the most studies (Bottrop)
Lead sponsorStudiesRecruiting
Eli Lilly and Company42
Gilead Sciences31
Alliance Foundation Trials, LLC.20
AstraZeneca21
Hoffmann-La Roche21
Institut fuer Frauengesundheit21
AbbVie10
Astellas Pharma Global Development, Inc.10
DualityBio Inc.10
Endomagnetics Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.